학술논문
Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan
Document Type
Article
Author
Yang, C.-C.; Kuo, H.-T.; Huang, C.-F.; Yeh, M.-L.; Huang, J.-F.; Tsai, P.-C.; Dai, C.-Y.; Chuang, W.-L.; Yu, M.-L.; Chang, T.-S.; Lo, C.-C.; Hung, C.-H.; Huang, C.-W.; Chong, L.-W.; Cheng, P.-N.; Peng, C.-Y.; Cheng, C.-Y.; Bair, M.-J.; Lin, C.-L.; Yang, C.-C.; Wang, S.-J.; Hsieh, T.-Y.; Chen, C.-T.; Lee, T.-H.; Lee, P.-L.; Wu, W.-C.; Lin, C.-L.; Su, W.-W.; Yang, S.-S.; Wang, C.-C.; Hu, J.-T.; Mo, L.-R.; Huang, Y.-H.; Lin, H.-C.; Chang, C.-C.; Huang, C.-S.; Chen, G.-Y.; Kao, C.-N.; Tai, C.-M.; Liu, C.-J.; Kao, J.-H.; Lee, M.-H.; Tseng, K.-C.; Chen, C.-Y.
Source
In: Infectious Diseases and Therapy . (Infectious Diseases and Therapy, June 2024, 13(6):1199-1213)
Subject
Language
English
ISSN
21936382
21938229
21938229